It depends what you consider the market.
Kaken basically had 200,000 new patients in the first year, I think BOT will have more.
Not only that. Every BOT patient that renews the script , effectively doubles the patient numbers, since most Japanese on average buy 1 script only. Most americans buy 2.
So although market penetration might oly be 2% or whatever.... if they renew 4 scripts on average.... that is the exquivalent of 4x market penetration in income.
Based on what happened in Japan, it is entirely feasable that the sales in year 1 will be around the 1 billion mark.
Take the same year 1 sales Kaken had, adjust for USA being 3 x the size, and adjust for the fact that USA on average renew 2 scripts where as Japan do not renew. That gives you 900,000 USD in sales ~ or about 1.3 to 1.4 Billion in AUS sales.
The first quarter report will be the first indication of where on that scale we are.
- Forums
- ASX - By Stock
- BOT
- Ann: Trading Halt
Ann: Trading Halt, page-280
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $567.0M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 33.3¢ | $14.94M | 42.66M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 112268 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 276101 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 106718 | 0.355 |
7 | 209285 | 0.350 |
4 | 167886 | 0.345 |
10 | 457729 | 0.340 |
9 | 406780 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 215033 | 5 |
0.365 | 376338 | 9 |
0.370 | 731746 | 11 |
0.375 | 616432 | 9 |
0.380 | 517894 | 7 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online